ASO Author Reflections: Emerging Risk Factors in Colon Cancer-End of the Line for Clinomics?

Ann Surg Oncol. 2020 Apr;27(4):1046-1047. doi: 10.1245/s10434-019-08149-2. Epub 2019 Dec 28.

Authors

Erik Osterman^{1

2}, Bengt Glimelius^{3

4}

Affiliations

¹ Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. erik.osterman@igp.uu.se.
² Department of Surgery, Gävle Hospital, Gävle, Sweden. erik.osterman@igp.uu.se.
³ Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
⁴ Department of Oncology, Uppsala University Hospital, Uppsala, Sweden.

No abstract available

MeSH terms

Biomarkers, Tumor / blood
Carcinoembryonic Antigen / blood
Colonic Neoplasms / epidemiology
Colonic Neoplasms / pathology*
Colonic Neoplasms / surgery*
Humans
Neoplasm Recurrence, Local*
Neoplasm Staging
Precision Medicine / methods*
Registries*
Risk Assessment
Risk Factors
Sweden / epidemiology
Treatment Outcome

Substances

Biomarkers, Tumor
Carcinoembryonic Antigen